ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

ACS Announces New Awards for Nurses

October 30, 1987

NCI Test Panels Available For Marker Evaluation

March 2, 1984

Ohio State, Hawaii Name New Center Directors; Berlin Acting Director At Papanicolaou

July 29, 1988